Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene. The newly found marker could help doctors classify each breast cancer patient ...
Aug 20, 2014
not rated yet | 0
Just a week after the controversy over breast cancer drug Kadcyla, the inflexibilities within the UK's disparate drug approval systems have been pulled into sharp focus once again.
Aug 18, 2014
5 / 5 (1) | 0